38,733 Shares in Sight Sciences Inc (NASDAQ:SGHT) Purchased by Jennison Associates LLC

Jennison Associates LLC acquired a new position in shares of Sight Sciences Inc (NASDAQ:SGHT) in the third quarter, Holdings Channel.com reports. The institutional investor acquired 38,733 shares of the company’s stock, valued at approximately $879,000.

Separately, Advisor Group Holdings Inc. purchased a new stake in Sight Sciences during the third quarter worth about $45,000. 49.01% of the stock is owned by institutional investors and hedge funds.

In related news, Director Staffan Encrantz bought 86,454 shares of the company’s stock in a transaction on Monday, November 29th. The stock was acquired at an average cost of $18.85 per share, for a total transaction of $1,629,657.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jesse Selnick bought 10,000 shares of the company’s stock in a transaction on Tuesday, November 23rd. The shares were bought at an average price of $18.44 per share, with a total value of $184,400.00. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 838,108 shares of company stock valued at $19,270,384.

A number of analysts recently issued reports on SGHT shares. Zacks Investment Research upgraded shares of Sight Sciences from a “hold” rating to a “buy” rating and set a $18.00 price objective for the company in a report on Wednesday. Morgan Stanley upgraded shares of Sight Sciences from an “equal weight” rating to an “overweight” rating and reduced their target price for the stock from $36.00 to $27.00 in a research note on Friday, January 7th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $36.00.

SGHT opened at $15.88 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 27.91 and a quick ratio of 27.62. The stock has a 50-day simple moving average of $19.43. Sight Sciences Inc has a twelve month low of $15.16 and a twelve month high of $42.57.

Sight Sciences (NASDAQ:SGHT) last posted its earnings results on Wednesday, November 10th. The company reported ($0.43) earnings per share for the quarter, missing the consensus estimate of ($0.38) by ($0.05). The firm had revenue of $13.10 million for the quarter, compared to analysts’ expectations of $12.25 million. On average, equities research analysts anticipate that Sight Sciences Inc will post -3.25 EPS for the current fiscal year.

Sight Sciences Profile

Sight Sciences Inc is a medical device company. It focused on the development and commercialization of proprietary devises which target the underlying causes of prevalent eye diseases. Sight Sciences Inc is based in MENLO PARK, Calif.

Read More: Intrinsic Value and Stock Selection

Want to see what other hedge funds are holding SGHT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sight Sciences Inc (NASDAQ:SGHT).

Institutional Ownership by Quarter for Sight Sciences (NASDAQ:SGHT)

Receive News & Ratings for Sight Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sight Sciences and related companies with MarketBeat.com's FREE daily email newsletter.